February 28, 2023

Biotalys Reports Full-Year 2022 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
January 31, 2023

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
January 26, 2023

Biotalys Achieves Significant Progress in Manufacturing Capabilities for Evoca

PDF icon
EN PDF icon
NL
January 3, 2023

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
December 27, 2022

Results of the Extraordinary Shareholders’ Meeting

PDF icon
EN PDF icon
NL
December 1, 2022

Biotalys Creates Scientific Advisory Committee with Leading Experts

PDF icon
EN PDF icon
NL
November 25, 2022

Invitation to an Extraordinary Shareholders’ Meeting

PDF icon
EN PDF icon
NL
November 7, 2022

Biotalys announces participation at investor and industry events for the remainder of 2022

PDF icon
EN PDF icon
NL
October 31, 2022

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
October 24, 2022

Biotalys and Novozymes announce successful Evoca™ feasibility study

PDF icon
EN PDF icon
NL
September 13, 2022

Biotalys announces participation at investor and industry events for the upcoming months

PDF icon
EN PDF icon
NL
August 19, 2022

Biotalys Reports Half-Year 2022 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
July 29, 2022

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
June 21, 2022

Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca™

PDF icon
EN PDF icon
NL
May 25, 2022

Biotalys’ First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product

PDF icon
EN PDF icon
NL